BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36474935)

  • 1. The effect of intra-articular extended-release triamcinolone acetonide on OARSI-recommended physical performance measures in adults with bilateral symptomatic knee osteoarthritis.
    Segal NA; Alm JC
    Osteoarthr Cartil Open; 2022 Sep; 4(3):100268. PubMed ID: 36474935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis.
    Langworthy MJ; Conaghan PG; Ruane JJ; Kivitz AJ; Lufkin J; Cinar A; Kelley SD
    Adv Ther; 2019 Jun; 36(6):1398-1411. PubMed ID: 30968336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Treatment Effect of Triamcinolone Acetonide Extended-Release in Patients with Concordant Baseline Pain Scores on the Average Daily Pain and Western Ontario and McMaster Universities Osteoarthritis Index Pain Scales.
    Ross E; Katz NP; Conaghan PG; Kivitz A; Turk DC; Spitzer AI; Jones DG; Lanier RK; Cinar A; Lufkin J; Kelley SD
    Pain Ther; 2022 Mar; 11(1):289-302. PubMed ID: 34791634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, phase IIa study to assess the systemic exposure of triamcinolone acetonide following injection of extended-release triamcinolone acetonide or traditional triamcinolone acetonide into both knees of patients with bilateral knee osteoarthritis.
    Kivitz A; Kwong L; Shlotzhauer T; Lufkin J; Cinar A; Kelley S
    Ther Adv Musculoskelet Dis; 2019; 11():1759720X19881309. PubMed ID: 31662801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open-Label, Randomized Study.
    Hanson P; Kivitz A; Mehra P; Kwong L; Cinar A; Lufkin J; Kelley SD
    Drugs R D; 2021 Sep; 21(3):285-293. PubMed ID: 34350546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA).
    Kraus VB; Conaghan PG; Aazami HA; Mehra P; Kivitz AJ; Lufkin J; Hauben J; Johnson JR; Bodick N
    Osteoarthritis Cartilage; 2018 Jan; 26(1):34-42. PubMed ID: 29024802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The OARSI core set of performance-based measures for knee osteoarthritis is reliable but not valid and responsive.
    Tolk JJ; Janssen RPA; Prinsen CAC; Latijnhouwers DAJM; van der Steen MC; Bierma-Zeinstra SMA; Reijman M
    Knee Surg Sports Traumatol Arthrosc; 2019 Sep; 27(9):2898-2909. PubMed ID: 29128879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-articular autologous conditioned serum and triamcinolone injections in patients with knee osteoarthritis: a controlled, randomized, double-blind study.
    Damjanov N; Zekovic A
    J Int Med Res; 2023 Oct; 51(10):3000605231203851. PubMed ID: 37818751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial.
    Bodick N; Lufkin J; Willwerth C; Kumar A; Bolognese J; Schoonmaker C; Ballal R; Hunter D; Clayman M
    J Bone Joint Surg Am; 2015 Jun; 97(11):877-88. PubMed ID: 26041848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsiveness and minimal important changes of the OARSI core set of performance-based measures in patients with knee osteoarthritis following physiotherapy intervention.
    Mostafaee N; Rashidi F; Negahban H; Ebrahimzadeh MH
    Physiother Theory Pract; 2024 May; 40(5):1028-1039. PubMed ID: 36346362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Repeat Administration of Triamcinolone Acetonide Extended-release in Osteoarthritis of the Knee: A Phase 3b, Open-label Study.
    Spitzer AI; Richmond JC; Kraus VB; Gomoll A; Jones DG; Huffman KM; Peterfy C; Cinar A; Lufkin J; Kelley SD
    Rheumatol Ther; 2019 Mar; 6(1):109-124. PubMed ID: 30741382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue Analgesic Medication Use by Patients Treated with Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinical Trials.
    Kivitz AJ; Conaghan PG; Cinar A; Lufkin J; Kelley SD
    Pain Ther; 2019 Dec; 8(2):271-280. PubMed ID: 31066021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study.
    Russell SJ; Sala R; Conaghan PG; Habib G; Vo Q; Manning R; Kivitz A; Davis Y; Lufkin J; Johnson JR; Kelley S; Bodick N
    Rheumatology (Oxford); 2018 Dec; 57(12):2235-2241. PubMed ID: 30203101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of GreenShell Mussel Powder (Brand-Named PERNAULTRA) on Physical Performance and Subjective Pain, Symptoms, and Function Measures in Knee Osteoarthritis: A 6-Mo Randomized, Double-Blind, Placebo-Controlled Trial.
    Slade CA; Kruger MC; Miller MR; Mazahery H; Beck KL; Conlon CA; von Hurst PR
    Curr Dev Nutr; 2024 Apr; 8(4):102148. PubMed ID: 38645882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-Articular, Single-Shot Hylan G-F 20 Hyaluronic Acid Injection Compared with Corticosteroid in Knee Osteoarthritis: A Double-Blind, Randomized Controlled Trial.
    Tammachote N; Kanitnate S; Yakumpor T; Panichkul P
    J Bone Joint Surg Am; 2016 Jun; 98(11):885-92. PubMed ID: 27252432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-articular platelet-rich plasma vs corticosteroids in the treatment of moderate knee osteoarthritis: a single-center prospective randomized controlled study with a 1-year follow up.
    Elksniņš-Finogejevs A; Vidal L; Peredistijs A
    J Orthop Surg Res; 2020 Jul; 15(1):257. PubMed ID: 32650801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual Participant Symptom Responses to Intra-Articular Lorecivivint in Knee Osteoarthritis: Post Hoc Analysis of a Phase 2B Trial.
    Tambiah JRS; Kennedy S; Swearingen CJ; Simsek I; Yazici Y; Farr J; Conaghan PG
    Rheumatol Ther; 2021 Jun; 8(2):973-985. PubMed ID: 34101138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Pain and Function with Triamcinolone Acetonide Extended-Release and Cryoneurolysis for Knee Osteoarthritis: Use of a New Real-World Registry.
    Mont MA; Lin JH; Spitzer AI; Dasa V; Rivadeneyra A; Rogenmoser D; Concoff AL; Ng MK; DiGiorgi M; DySart S; Urban J; Mihalko WM
    J Arthroplasty; 2024 Jun; ():. PubMed ID: 38936436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triamcinolone Acetonide Extended-Release: A Review in Osteoarthritis Pain of the Knee.
    Paik J; Duggan ST; Keam SJ
    Drugs; 2019 Mar; 79(4):455-462. PubMed ID: 30847805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Methylprednisolone Acetate Versus Triamcinolone Acetonide Intra-articular Knee Injection in Patients With Chronic Inflammatory Arthritis: A 24-Week Randomized Controlled Trial.
    Kumar A; Dhir V; Sharma S; Sharma A; Singh S
    Clin Ther; 2017 Jan; 39(1):150-158. PubMed ID: 28012569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.